Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Apr 20, 2018

---

• Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers  
  J Kotsopolous et al, JAMA Oncology, Apr 2019
• Malignant Abnormalities in Male BRCA Mutation Carriers Results From a Prospectively Screened Cohort  
  R Mano et al, JAMA Oncology, Apr 2018
• Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome  
  K Chang et al, JAMA Onc, Apr 16, 2018
• Are we ready for routine precision medicine? Highlights from the Milan Summit on Precision Medicine, Milan, Italy, 8-9 February 2018.  
  Mazzarella Luca et al. Ecancermedicalscience 2018 12817
• Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers.  
  Groisberg Roman et al. Molecular cancer therapeutics 2018 Apr
• Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population.  
  Cenin Dayna R et al. Journal of gastroenterology and hepatology 2018 Apr
• Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study.  
  Katapodi Maria C et al. JMIR cancer 2018 Apr 4(1) e7
• Feasibility study of cancer genome alterations identified by next generation sequencing: ABC study.  
  Naito Yoichi et al. Japanese journal of clinical oncology 2018 Apr
• Genetics of personalized medicine: cancer and rare diseases.  
  Alves Inês Teles Siefers et al. Cellular oncology (Dordrecht) 2018 Apr
• Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.  
  Hellmann Matthew D et al. Cancer cell 2018 Apr